Skip to content
Screener

CorMedix CRMD Price / earnings

Price / earnings at other companies

Pfizer logo
PfizerPFE
14.7×—
Merck & Co. logo
Merck & Co.MRK
100×+87.7×
Merit Medical Systems logo
Merit Medical SystemsMMSI
29.4×-21.5×
IAR
Integra LifeSciencesIART
95.8×+70.8×
TFX
TeleflexTFX
27.7×-9.9×
Medline, Inc. logo
Medline, Inc.MDLN
37.5×—

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$583.68M-22.4%
P/S1.5×-4.7×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%—
Net margin45.2%—
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%—
Debt / equity0×0.0×
Current ratio3×-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

market cap/net income=3×

Based on the most recent quarter.

The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 8:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001410098-26-000021

FAQ

What is CorMedix's price / earnings?
CorMedix (CRMD) reported price / earnings of 3× in Q1 2026.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about CorMedix's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude